Top

Published in:

01-08-2018 | Original Research

Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives

Authors: Kelly A. Duffy, Katheryn L. Grand, Kristin Zelley, Jennifer M. Kalish

Published in: Journal of Genetic Counseling | Issue 4/2018

Abstract

Children with Beckwith-Wiedemann Syndrome (BWS) and Isolated Hemihypertrophy (IHH) are at an increased risk for developing tumors. Tumor screening in this population is currently being reassessed by several groups and the effect on patients and patient-families has been argued both as a reason to screen and not to screen. Parental perspectives on this topic have never been systematically addressed for the BWS population. Here, we conducted a parent-based survey to evaluate knowledge and attitudes toward tumor screening in patients affected by BWS/IHH. A total of 261 surveys were completed. Overall, parents reported that screening decreased their worry and did not feel that screening increased worry or created a burden. This effect was observed across various demographic variables and other factors examined. Almost all significant differences observed could be attributed to parental knowledge of tumor risk. Parents who correctly identified their child’s tumor risk were more likely to agree with stratified screening recommendations according to BWS type and risk, and were less likely to feel worried if recommendations were changed. These results highlight the need to educate families about their child’s genetic type and tumor risk in order to facilitate an informed decision about tumor screening.

Available only for authorised users

Beckwith, J. B. (1998). Children at increased risk for Wilms tumor: Monitoring issues. The Journal of Pediatrics, 132(3 Pt 1), 377–379.CrossRefPubMed

Brioude, F., Lacoste, A., Netchine, I., Vazquez, M. P., Auber, F., Audry, G., et al. (2013). Beckwith-Wiedemann syndrome: Growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Hormone Research in Pædiatrics, 80(6), 457–465. https://doi.org/10.1159/000355544.CrossRefPubMed

Budych, K., Helms, T. M., & Schultz, C. (2012). How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction. Health Policy, 105(2–3), 154–164. https://doi.org/10.1016/j.healthpol.2012.02.018.CrossRefPubMed

Choyke, P. L., Siegel, M. J., Craft, A. W., Green, D. M., & DeBaun, M. R. (1999). Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Medical and Pediatric Oncology, 32(3), 196–200.CrossRefPubMed

Clericuzio, C. L., & Martin, R. A. (2009). Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genetics in Medicine, 11(3), 220–222. https://doi.org/10.1097/GIM.0b013e31819436cf.CrossRefPubMedPubMedCentral

Cooper, W. N., Luharia, A., Evans, G. A., Raza, H., Haire, A. C., Grundy, R., et al. (2005). Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. European Journal of Human Genetics, 13(9), 1025–1032. https://doi.org/10.1038/sj.ejhg.5201463.CrossRefPubMed

DeBaun, M. R., & Tucker, M. A. (1998). Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. The Journal of Pediatrics, 132(3 Pt 1), 398–400.CrossRefPubMed

DeBaun, M. R., Brown, M., & Kessler, L. (1996). Screening for Wilms' tumor in children with high-risk congenital syndromes: Considerations for an intervention trial. Medical and Pediatric Oncology, 27(5), 415–421. https://doi.org/10.1002/(SICI)1096-911X(199611)27:5<415::AID-MPO5>3.0.CO;2-P.CrossRefPubMed

Eggermann, T., Algar, E., Lapunzina, P., Mackay, D., Maher, E. R., Mannens, M., et al. (2014). Clinical utility gene card for: Beckwith-Wiedemann syndrome. European Journal of Human Genetics, 22(3). doi:https://doi.org/10.1038/ejhg.2013.132.

Everman, D. B., Shuman, C., Dzolganovski, B., O'Riordan M, A., Weksberg, R., & Robin, N. H. (2000). Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. The Journal of Pediatrics, 137(1), 123–127. doi:https://doi.org/10.1067/mpd.2000.106217.

Gopie, J. P., Vasen, H. F., & Tibben, A. (2012). Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?--a systematic review. Critical Reviews in Oncology/Hematology, 83(3), 329–340. https://doi.org/10.1016/j.critrevonc.2012.01.004.CrossRefPubMed

Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010.CrossRefPubMed

Jordan, J. E., Buchbinder, R., & Osborne, R. H. (2010). Conceptualising health literacy from the patient perspective. Patient Education and Counseling, 79(1), 36–42. https://doi.org/10.1016/j.pec.2009.10.001.CrossRefPubMed

Kalish, J. M., & Deardorff, M. A. (2016). Tumor screening in Beckwith-Wiedemann syndrome-to screen or not to screen? American Journal of Medical Genetics. Part A, 170(9), 2261–2264. https://doi.org/10.1002/ajmg.a.37881.CrossRefPubMedPubMedCentral

Kalish, J. M., Doros, L., Helman, L. J., Hennekam, R. C., Kuiper, R. P., Maas, S. M., et al. (2017). Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and Hepatoblastoma. Clinical Cancer Research Pediatric Oncology Series, 23(13), e115–e122.

Lapunzina, P. (2005). Risk of tumorigenesis in overgrowth syndromes: A comprehensive review. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 137C(1), 53–71. https://doi.org/10.1002/ajmg.c.30064.CrossRefPubMed

Maas, S. M., Vansenne, F., Kadouch, D. J., Ibrahim, A., Bliek, J., Hopman, S., et al. (2016). Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. American Journal of Medical Genetics. Part A, 170(9), 2248–2260. https://doi.org/10.1002/ajmg.a.37801.CrossRefPubMed

McNeil, D. E., Brown, M., Ching, A., & DeBaun, M. R. (2001). Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: A cost-effective model. Medical and Pediatric Oncology, 37(4), 349–356.CrossRefPubMed

Mussa, A., Pagliardini, S., Pagliardini, V., Molinatto, C., Baldassarre, G., Corrias, A., et al. (2014). Alpha-fetoprotein assay on dried blood spot for hepatoblastoma screening in children with overgrowth-cancer predisposition syndromes. Pediatric Research, 76(6), 544–548. https://doi.org/10.1038/pr.2014.126.CrossRefPubMed

Mussa, A., Di Candia, S., Russo, S., Catania, S., De Pellegrin, M., Di Luzio, L., et al. (2016a). Recommendations of the scientific Committee of the Italian Beckwith-Wiedemann Syndrome Association on the diagnosis, management and follow-up of the syndrome. European Journal of Medical Genetics, 59(1), 52–64. https://doi.org/10.1016/j.ejmg.2015.11.008.CrossRefPubMed

Mussa, A., Molinatto, C., Baldassarre, G., Riberi, E., Russo, S., Larizza, L., et al. (2016b). Cancer risk in Beckwith-Wiedemann syndrome: A systematic review and meta-analysis outlining a novel (epi)genotype specific Histotype targeted screening protocol. The Journal of Pediatrics, 176(142–149), e141. https://doi.org/10.1016/j.jpeds.2016.05.038.CrossRef

Mussa, A., Russo, S., De Crescenzo, A., Freschi, A., Calzari, L., Maitz, S., et al. (2016c). (epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. European Journal of Human Genetics, 24(2), 183–190. https://doi.org/10.1038/ejhg.2015.88.CrossRefPubMed

Pappas, J. G. (2015). The clinical course of an overgrowth syndrome, from diagnosis in infancy through adulthood: The case of Beckwith-Wiedemann syndrome. Current Problems in Pediatric and Adolescent Health Care, 45(4), 112–117. https://doi.org/10.1016/j.cppeds.2015.03.001.CrossRefPubMed

Pritchard-Jones, K. (2002). Controversies and advances in the management of Wilms' tumour. Archives of Disease in Childhood, 87(3), 241–244.CrossRefPubMedPubMedCentral

Rump, P., Zeegers, M. P., & van Essen, A. J. (2005). Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. American Journal of Medical Genetics. Part A, 136(1), 95–104. https://doi.org/10.1002/ajmg.a.30729.CrossRefPubMed

Scott, R. H., Walker, L., Olsen, O. E., Levitt, G., Kenney, I., Maher, E., et al. (2006). Surveillance for Wilms tumour in at-risk children: Pragmatic recommendations for best practice. Archives of Disease in Childhood, 91(12), 995–999. https://doi.org/10.1136/adc.2006.101295.CrossRefPubMedPubMedCentral

Shah, K. J. (1983). Beckwith-Wiedemann syndrome: Role of ultrasound in its management. Clinical Radiology, 34(3), 313–319.CrossRefPubMed

Smith, S. K., Dixon, A., Trevena, L., Nutbeam, D., & McCaffery, K. J. (2009). Exploring patient involvement in healthcare decision making across different education and functional health literacy groups. Social Science & Medicine, 69(12), 1805–1812. https://doi.org/10.1016/j.socscimed.2009.09.056.CrossRef

Tan, T. Y., & Amor, D. J. (2006). Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: A critical review of the evidence and suggested guidelines for local practice. Journal of Paediatrics and Child Health, 42(9), 486–490. https://doi.org/10.1111/j.1440-1754.2006.00908.x.CrossRefPubMed

Teplick, A., Kowalski, M., Biegel, J. A., & Nichols, K. E. (2011). Educational paper: Screening in cancer predisposition syndromes: Guidelines for the general pediatrician. European Journal of Pediatrics, 170(3), 285–294. https://doi.org/10.1007/s00431-010-1377-2.CrossRefPubMedPubMedCentral

Verge, C. F., & Mowat, D. (2010). Overgrowth. Archives of Disease in Childhood, 95(6), 458–463. https://doi.org/10.1136/adc.2009.157693.CrossRefPubMed

Weksberg, R., Shuman, C., & Beckwith, J. B. (2010). Beckwith-Wiedemann syndrome. European Journal of Human Genetics, 18(1), 8–14. https://doi.org/10.1038/ejhg.2009.106.CrossRefPubMed

Weng, E. Y., Moeschler, J. B., & Graham, J. M., Jr. (1995). Longitudinal observations on 15 children with Wiedemann-Beckwith syndrome. American Journal of Medical Genetics, 56(4), 366–373. doi:https://doi.org/10.1002/ajmg.1320560405.

Woolf, S. H., Chan, E. C., Harris, R., Sheridan, S. L., Braddock 3rd, C. H., Kaplan, R. M., et al. (2005). Promoting informed choice: Transforming health care to dispense knowledge for decision making. Annals of Internal Medicine, 143(4), 293–300.CrossRefPubMed

Zarate, Y. A., Mena, R., Martin, L. J., Steele, P., Tinkle, B. T., & Hopkin, R. J. (2009). Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol. American Journal of Medical Genetics. Part A, 149A(8), 1691–1697. https://doi.org/10.1002/ajmg.a.32966.CrossRefPubMed

Title: Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives
Authors: Kelly A. Duffy
Katheryn L. Grand
Kristin Zelley
Jennifer M. Kalish
Publication date: 01-08-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 4/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-017-0182-8

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Genesurance Counseling: Genetic Counselors’ Roles and Responsibilities in Regards to Genetic Insurance and Financial Topics

Reproductive Decision Support: Preferences and Needs of Couples at Risk for Hereditary Cancer and Clinical Geneticists

Movement of Genetic Counselors from Clinical to Non-clinical Positions: Identifying Driving Forces

Issue Highlights

Identification as a Mutation Carrier and Effects on Life According to Experiences of Finnish Male BRCA1/2 Mutation Carriers

Challenges, Dilemmas and Factors Involved in PGD Decision-Making: Providers’ and Patients’ Views, Experiences and Decisions